Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Systemic Sclerosis

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

Rheumatology (Oxford)

Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C, Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V, Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S, Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O, Elhai M, EUSTAR collaborators

doi: 10.1093/rheumatology/keaf016

Systemic Sclerosis

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

J Autoimmun

Chaigne B, Bense A, Aubourg F, Agard C, Allanore Y, Berezne A, Pugnet G, Hachulla E, Cottin V, Hot A, Dunogue B, Kanagaratnam A, Palat S, Lescoat A, Berthier S, Chatelus E, Rivière S, Launay D, Truchetet ME, Dinh-Xuan AT, Mouthon L, French Systemic Sclerosis Network

doi: 10.1016/j.jaut.2025.103391

Rheumatoid Arthritis

Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis

Semin Arthritis Rheum

Zhang Q, McDermott GC, Juge PA, Chang SH, Vanni KM, Qian G, Bade KJ, Mueller KT, Kowalski EN, Saavedra AA, Sparks JA

doi: 10.1016/j.semarthrit.2024.152561

Rheumatoid Arthritis

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Arthritis Res Ther

Ramien R, Rudi T, Alten R, Krause A, Schneider M, Schaefer M, Strangfeld A, Meissner Y

doi: 10.1186/s13075-024-03449-9

Systemic Sclerosis

Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study

Rheumatology (Oxford)

De Luca G, De Lorenzis E, Campochiaro C, Cacciapaglia F, Del Papa N, Zanatta E, Airò P, Lazzaroni MG, Giuggioli D, De Santis M, Alonzi G, Stano S, Binda M, Moccaldi B, Tonutti A, Cavalli S, Batani V, Natalello G, Iannone F, D'Agostino MA, Dagna L, Matucci-Cerinic M, Bosello SL

doi: 10.1093/rheumatology/keae280

Rheumatoid Arthritis

Quantitative Computed Tomography Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease

Chest

Humphries SM, Adegunsoye A, Demoruelle MK, Wei Kam ML, Amigues I, Bang TJ, Teague SD, Lynch DA, Chung JH, Strek ME, Swigris JJ, Solomon JJ

doi: 10.1016/j.chest.2024.10.052

Further Publications Immunology

Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022: an interim analysis using the French JIR cohort database

Arthritis Res Ther

Koné-Paut I, Georgin-Lavialle S, Belot A, Jover M, Pouriel M, Lacoin L, Pillet P, Hentgen V

doi: 10.1186/s13075-024-03316-7

Systemic Lupus Erythematosus

Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort

Semin Arthritis Rheum

Deffendall C, Green S, Suh A, Nikolova N, Walker K, Whitney R, Wheless L, Osmundson S, Barnado A

doi: 10.1016/j.semarthrit.2024.152603

Autoimmune DiseaseFurther Publications Rheumatology

Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers with Autoimmune or Inflammatory Rheumatic Disease (AIRD): A Retrospective Cohort Analysis from the National COVID Cohort Collaborative (N3C)

Arthritis Care Res (Hoboken)

Anzalone AJ, Jackson LE, Singh N, Danila MI, Reisher E, Patel RC, Singh JA, National COVID Cohort Collaborative (N3C) Consortium

doi: 10.1002/acr.25421

Related content

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study

Quantitative Computed Tomography Analysis in Rheumatoid Arthritis-Related Interstitial Lung Disease

Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022: an interim analysis using the French JIR cohort database

Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort

Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers with Autoimmune or Inflammatory Rheumatic Disease (AIRD): A Retrospective Cohort Analysis from the National COVID Cohort Collaborative (N3C)